S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
OTCMKTS:AOBI

American Oriental Bioengineering Stock Forecast, Price & News

$2.75
0.00 (0.00 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.75
$2.75
50-Day Range
$0.05
$2.75
52-Week Range
$0.01
$6.75
Volume4 shs
Average Volume258 shs
Market Capitalization$200,750.00
P/E RatioN/A
Dividend YieldN/A
Beta-10.35
30 days | 90 days | 365 days | Advanced Chart
Receive AOBI News and Ratings via Email

Sign-up to receive the latest news and ratings for American Oriental Bioengineering and its competitors with MarketBeat's FREE daily newsletter.


About American Oriental Bioengineering

American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of pharmaceutical and healthcare products. It operates through the manufacturing and distribution segments. Its products include prescription pharmaceutical, over-the-counter pharmaceutical, and nutraceutical products. The company was founded by Shujun Liu, Yanchun Li, and Jun Min on November 30, 1970 and is headquartered in Beijing, China.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AOBI
CIK
N/A
Employees
2,012
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$200,750.00
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.16 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












American Oriental Bioengineering (OTCMKTS:AOBI) Frequently Asked Questions

What stocks does MarketBeat like better than American Oriental Bioengineering?

Wall Street analysts have given American Oriental Bioengineering a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but American Oriental Bioengineering wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has American Oriental Bioengineering's stock price been impacted by COVID-19?

American Oriental Bioengineering's stock was trading at $5.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AOBI shares have decreased by 45.0% and is now trading at $2.75.
View which stocks have been most impacted by COVID-19
.

Who are American Oriental Bioengineering's key executives?

American Oriental Bioengineering's management team includes the following people:
  • Shujun Liu, Chairman & Chief Executive Officer
  • Yan Chun Li, Chief Financial Officer & Chief Operating Officer

What other stocks do shareholders of American Oriental Bioengineering own?

Based on aggregate information from My MarketBeat watchlists, some companies that other American Oriental Bioengineering investors own include Nokia (NOK), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Abacus Property Group (ABP), Advanced Biomedical Technologies (ABMT), Abiomed (ABMD), ARCA biopharma (ABIO), Abeona Therapeutics (ABEO) and Abcam (ABCZY).

What is American Oriental Bioengineering's stock symbol?

American Oriental Bioengineering trades on the OTCMKTS under the ticker symbol "AOBI."

How do I buy shares of American Oriental Bioengineering?

Shares of AOBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is American Oriental Bioengineering's stock price today?

One share of AOBI stock can currently be purchased for approximately $2.75.

How much money does American Oriental Bioengineering make?

American Oriental Bioengineering has a market capitalization of $200,750.00.

How many employees does American Oriental Bioengineering have?

American Oriental Bioengineering employs 2,012 workers across the globe.

What is American Oriental Bioengineering's official website?

The official website for American Oriental Bioengineering is www.bioaobo.com.

Where are American Oriental Bioengineering's headquarters?

American Oriental Bioengineering is headquartered at NO 4018 JINTIAN ROAD ANLIAN PLAZA 12F SUITE B02, SHENZHEN F4, 518026.

How can I contact American Oriental Bioengineering?

American Oriental Bioengineering's mailing address is NO 4018 JINTIAN ROAD ANLIAN PLAZA 12F SUITE B02, SHENZHEN F4, 518026. The company can be reached via phone at 861059822039 or via email at [email protected].


This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.